Clinical Trial Update: Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease [NA]

View source ↗

Summary

This clinical trial update indicates that a study evaluating sirolimus for refractory adult-onset Still's disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Ruijin Hospital | Conditions: Adult-Onset Still's Disease | NA | Status: ACTIVE_NOT_RECRUITING